Zimmer Biomet Statistics Share Statistics Zimmer Biomet has 197.85M
shares outstanding. The number of shares has increased by -2.85%
in one year.
Shares Outstanding 197.85M Shares Change (YoY) -2.85% Shares Change (QoQ) -0.61% Owned by Institutions (%) 91.7% Shares Floating 197.82M Failed to Deliver (FTD) Shares 62 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.34M, so 3.71% of the outstanding
shares have been sold short.
Short Interest 7.34M Short % of Shares Out 3.71% Short % of Float 4.25% Short Ratio (days to cover) 3.87
Valuation Ratios The PE ratio is 23.74 and the forward
PE ratio is 11.95.
Zimmer Biomet's PEG ratio is
-2.53.
PE Ratio 23.74 Forward PE 11.95 PS Ratio 2.79 Forward PS 2.3 PB Ratio 1.72 P/FCF Ratio 18.78 PEG Ratio -2.53
Financial Ratio History Enterprise Valuation Zimmer Biomet has an Enterprise Value (EV) of 27.13B.
EV / Sales 3.53 EV / EBITDA 12.05 EV / EBIT 18.1 EV / FCF 23.75
Financial Position The company has a current ratio of 1.91,
with a Debt / Equity ratio of 0.5.
Current Ratio 1.91 Quick Ratio 0.99 Debt / Equity 0.5 Debt / EBITDA 2.76 Debt / FCF 5.43 Interest Coverage 5.9
Financial Efficiency Return on Equity is 7.25% and Return on Invested Capital is 5.68%.
Return on Equity 7.25% Return on Assets 4.23% Return on Invested Capital 5.68% Revenue Per Employee $451.68K Profits Per Employee $53.16K Employee Count 17,000 Asset Turnover 0.36 Inventory Turnover 0.98
Taxes Income Tax 131.4M Effective Tax Rate 12.68%
Stock Price Statistics The stock price has increased by -6.52% in the
last 52 weeks. The beta is 0.68, so Zimmer Biomet's
price volatility has been higher than the market average.
Beta 0.68 52-Week Price Change -6.52% 50-Day Moving Average 93.36 200-Day Moving Average 102.31 Relative Strength Index (RSI) 62.89 Average Volume (20 Days) 2,092,817
Income Statement In the last 12 months, Zimmer Biomet had revenue of 7.68B
and earned 903.8M
in profits. Earnings per share was 4.45.
Revenue 7.68B Gross Profit 5.49B Operating Income 1.29B Net Income 903.8M EBITDA 2.25B EBIT 1.25B Earnings Per Share (EPS) 4.45
Full Income Statement Balance Sheet The company has 525.5M in cash and 6.2B in
debt, giving a net cash position of -5.68B.
Cash & Cash Equivalents 525.5M Total Debt 6.2B Net Cash -5.68B Retained Earnings 11.1B Total Assets 22.87B Working Capital 3.17B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 1.5B
and capital expenditures -356.8M, giving a free cash flow of 1.14B.
Operating Cash Flow 1.5B Capital Expenditures -356.8M Free Cash Flow 1.14B FCF Per Share 5.63
Full Cash Flow Statement Margins Gross margin is 71.46%, with operating and profit margins of 16.74% and 11.77%.
Gross Margin 71.46% Operating Margin 16.74% Pretax Margin 13.5% Profit Margin 11.77% EBITDA Margin 29.31% EBIT Margin 16.74% FCF Margin 14.88%
Dividends & Yields ZBH pays an annual dividend of $1.2,
which amounts to a dividend yield of 1.05%.
Dividend Per Share $1.20 Dividend Yield 1.05% Dividend Growth (YoY) 0% Payout Ratio 29.27% Earnings Yield 4.21% FCF Yield 5.33%
Dividend Details Analyst Forecast The average price target for ZBH is $113,
which is 13% higher than the current price. The consensus rating is "Hold".
Price Target $113 Price Target Difference 13% Analyst Consensus Hold Analyst Count 19
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 78.4 Graham Upside -21.62%
Stock Splits The last stock split was on Mar 1, 2022. It was a
forward
split with a ratio of 103:100.
Last Split Date Mar 1, 2022 Split Type forward Split Ratio 103:100
Scores Altman Z-Score 2.75 Piotroski F-Score 7
